Agid Y - Search Results

1

Decreased ferritin levels in brain in Parkinson's disease.

Dexter DT, Carayon A, Vidailhet M, Ruberg M, Agid F, Agid Y, Lees AJ, Wells FR, Jenner P, Marsden CD. Dexter DT, et al. Among authors: agid f, agid y. J Neurochem. 1990 Jul;55(1):16-20. doi: 10.1111/j.1471-4159.1990.tb08814.x. J Neurochem. 1990. PMID: 2355217

2

Brain muscarinic cholinergic receptors in Huntington's disease.

Lange KW, Javoy-Agid F, Agid Y, Jenner P, Marsden CD. Lange KW, et al. Among authors: agid y. J Neurol. 1992 Feb;239(2):103-4. doi: 10.1007/BF00862983. J Neurol. 1992. PMID: 1532417 Free article.

3

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.

Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD. Dexter DT, et al. Among authors: agid y. Brain. 1991 Aug;114 ( Pt 4):1953-75. doi: 10.1093/brain/114.4.1953. Brain. 1991. PMID: 1832073

4

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.

Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD. Dexter DT, et al. Among authors: agid f, agid y. J Neurochem. 1989 Jun;52(6):1830-6. doi: 10.1111/j.1471-4159.1989.tb07264.x. J Neurochem. 1989. PMID: 2723638

5

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.

Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD. Dexter DT, et al. Among authors: agid y. J Neurochem. 1989 Feb;52(2):381-9. doi: 10.1111/j.1471-4159.1989.tb09133.x. J Neurochem. 1989. PMID: 2911023

6

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.

Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD. Sian J, et al. Among authors: agid y. Ann Neurol. 1994 Sep;36(3):348-55. doi: 10.1002/ana.410360305. Ann Neurol. 1994. PMID: 8080242

7

Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease.

Temlett JA, Quinn NP, Jenner PG, Marsden CD, Pourcher E, Bonnet AM, Agid Y, Markstein R, Lataste X. Temlett JA, et al. Among authors: agid y. Mov Disord. 1989;4(3):261-5. doi: 10.1002/mds.870040307. Mov Disord. 1989. PMID: 2571082

8

Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's disease.

Javoy-Agid F, Taquet H, Ploska A, Cherif-Zahar C, Ruberg M, Agid Y. Javoy-Agid F, et al. Among authors: agid y. J Neurochem. 1981 Jun;36(6):2101-5. doi: 10.1111/j.1471-4159.1981.tb10843.x. J Neurochem. 1981. PMID: 7241152 No abstract available.

9

Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?

Ruberg M, Brugg B, Prigent A, Hirsch E, Brice A, Agid Y. Ruberg M, et al. Among authors: agid y. J Neurochem. 1997 May;68(5):2098-110. doi: 10.1046/j.1471-4159.1997.68052098.x. J Neurochem. 1997. PMID: 9109538 Free article.

10

Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset.

Jenner P, Taquet H, Mauborgne A, Benoliel JT, Cesselin F, Rose S, Javoy-Agid F, Agid Y, Marsden CD. Jenner P, et al. Among authors: agid y. J Neurochem. 1986 Nov;47(5):1548-51. doi: 10.1111/j.1471-4159.1986.tb00793.x. J Neurochem. 1986. PMID: 2428937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters